What can we do about patients presenting with myeloma and severe renal failure? Observations from the UK MERIT plasma exchange trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

What can we do about patients presenting with myeloma and severe renal failure? Observations from the UK MERIT plasma exchange trial

Published:2022-12-07 Issue:1 Volume:4 Page:246-250
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Behrens Judith¹,Gaskin Gill²,Iggo Neil³,Barratt Jonathan⁴,Tighe Jane⁵,Soutar Richard⁶,Cook Gordon⁷,Drake Mary⁸,Morris Curly⁹,Drayson Mark¹⁰

Affiliation:

1. Department of Haematology St Helier Hospital Carshalton UK

2. Department of Renal Medicine Hammersmith Hospital London UK

3. Sussex Kidney Unit Brighton and Sussex University Hospitals NHS Trust Brighton UK

4. Department of Cardiovascular Sciences John Walls Renal Unit, Leicester General Hospital Leicester UK

5. Department of Haematology Aberdeen Royal Infirmary Foresterhill UK

6. Department of Haematology Glasgow Royal Infirmary Glasgow Glasgow UK

7. Leeds Cancer Centre St. James University Hospital Leeds UK

8. Haematology Department Belfast City Hospital Belfast UK

9. Centre for Cancer Research and Cell Biology Queens University Belfast UK

10. Clinical Immunology Service University of Birmingham Birmingham UK

Funder

Cancer Research UK

Publisher

Wiley

Subject

General Earth and Planetary Sciences

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.620

Reference15 articles.

1. Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group

2. Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study

3. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma

4. Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials

5. Early Reduction of Serum-Free Light Chains Associates with Renal Recovery in Myeloma Kidney

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3